Pfizer CEO Albert Bourla says that company has reviewed its first AI-designed molecule.
He says the company wants to be at the forefront of using artificial intellegence
Pfizer beats Q1 earnings estimates
Bloomberg
— — 1min
Pfizer CEO Albert Bourla says that company has reviewed its first AI-designed molecule.
He says the company wants to be at the forefront of using artificial intellegence